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Abstract
In species whose evolutionary history has provided natural tolerance to dehydration and freezing,
metabolic depression is often a pre-requisite for survival. We tested the hypothesis that
preconditioning of mammalian cells with 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside
(AICAR) to achieve metabolic depression will promote greater survivorship during
cryopreservation. AICAR is used extensively to stimulate AMP-activated protein kinase (AMPK),
which can result in downregulation of biosynthetic processes. We showed that the metabolic
interconversion of AICAR was cell-type dependent. Accumulation of 5-aminoimidazole-4-
carboxamide-1b-D-ribofuranosyl-5′-monophosphate (ZMP), as well as other metabolites that
possess multiple phosphates (i.e., ZDP, ZTP), varied approximately 3.5-fold across the cell lines
tested. AICAR treatment also significantly influenced the concentrations of cellular adenylates
(ATP, ADP, AMP). Depression of cell metabolism and proliferation with AICAR treatment
differed among cell lines. Proliferation for a given cell line was negatively correlated with the
fold-increase achieved in the ‘effective adenylate ratio’ ([AMP]+[ZMP])/[ATP]) after AICAR
treatment. Metabolic preconditioning with AICAR promoted a significant increase in viability
post-freezing in J774.A1 macrophages, HepG2/C3A cells and primary hepatocytes but not in NIH/
3T3 fibroblasts or OMK cells. The effect of AICAR on viability after freezing was positively
correlated (r2 = 0.94) with the fold-increase in the ‘effective adenylate ratio’. Thus for each cell
line, the greater the depression of metabolism and proliferation due to preconditioning with
AICAR, the greater was the survivorship post-freezing.
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The ability of an animal to arrest development and metabolism before when faced with
environmental challenges like desiccation, anoxia, and freezing improves the survival of
many species [1-3]. By considering this lesson from nature, one key prediction that emerges
is that the placement of mammalian cells into stasis will foster greater survival of cells when
exposed to stabilization methods like dehydration, lyophilization, or cryopreservation. This
prediction is based on our understanding of the biological principles and criteria that
underlie naturally occurring states of dormancy, particularly diapause [4,5]. When animals
enter diapause, normal developmental programs are interrupted. Catabolic and anabolic
processes are downregulated in a coordinated fashion, which minimizes imbalances in
cellular processes that could lead to pathological conditions. In this regulated state of stasis,
diapausing animals are more tolerant of environmental stresses like anoxia and dehydration
[2,3,6,7]. Consequently, it is reasonable to hypothesize that mammalian cells, which
normally do not experience drying or freezing, may also benefit from preconditioning. In the
present study, we show for the first time that metabolic preconditioning improves cell
viability after freezing. Specifically, pre-treatment with 5-aminoimidazole-4-carboxamide-1-
b-D-ribofuranoside (AICAR)1 promotes a significant increase in survivorship post-freezing.
AICAR has the potential to mimic a number of the metabolic features associated with
diapause. Most of its effects on cell metabolism are exerted by its phosphorylated form
ZMP, which activates the enzyme AMP-activated protein kinase (EC2.7.11.27, AMPK)
[8,9]. AMPK is part of an ultrasensitive system for monitoring cellular energy changes and
can be considered a metabolic “fuel gauge” [10]. Under optimal physiological conditions,
the AMP:ATP ratio is maintained at approximately 0.01 [11]. An increase in AMP/ATP
activates AMPK by four different mechanisms: 1) allosteric activation of the enzyme by
binding to AMP, 2) allosteric activation of the upstream AMPK kinase LKB1, which
increases AMPK activity by phosphorylation of AMPK, 3) a decreased affinity of the
liganded AMPK for the protein phosphatase, and 4) an increased affinity of the liganded
AMPK to LKB1 [12-14]. The activation of the AMPK cascade leads to several metabolic
responses: an inhibition of anabolic pathways such as fatty acid synthesis, lipogenesis, and
cell proliferation, and conversely to an activation of selected catabolic pathways such as
fatty acid oxidation and glucose uptake. Furthermore, increased AMPK activity seems to
decrease or increase apoptosis depending on the experimental model [15,16].
A key feature that contributes to the popularity of AICAR is its ability to cross the cell
membrane through the nucleoside transporter [17]. After uptake into the cell, AICAR is
phosphorylated by adenosine kinase to form the membrane impermeable compound ZMP
[18], which enters the nucleotide pool before the IMP branch point [19]. ZMP mimics the
multiple effects of AMP on AMPK, which include allosteric activation and activation of the
upstream kinase LKB1 [8,9,20-22]. Cell-type specific differences in response to AICAR
have been reported [23]. Many investigators who use AICAR to activate AMPK do not
verify rigorously the conversion of AICAR to ZMP, nor do they optimize its concentration
and exposure time for maximum effect. Our results demonstrate major differences among
cell types in the ability to metabolize AICAR, in the accumulation of di- and tri-
phosphorylated forms of the compound, and in subsequent effects on cell function. Thus, the
common practice of ascribing the influence of AICAR exclusively to AMPK activation,
1In this paper, we refer to the membrane permeable, non-phosphorylated form of this analogue as AICAR, and the phosphorylated
compound as ZMP, based on the nomenclature of Hardy et al. [12]. In some references and databases, the phosphorylated compound
is designated as AICAR [e.g., http://www.genome.ad.jp; cpd: C04677; GenomeNet (Bioinformatics Center, Institute for Chemical
research, Kyoto University)].
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without first completing a thorough analysis of its metabolic impact on the chosen cell type,
is called into question.
MATERIALS AND METHODS
Chemicals
Tetrabutylammonium bisulfate and 2-deoxy-D-glucose were purchased from Sigma-Aldrich
(St. Louise, MO). Chemicals for HPLC analysis, including acetonitrile and potassium
phosphates, were obtained from Fisher Scientific (Pittsburgh, PA). AICAR and ZMP were
purchased from Toronto Research Chemicals Inc. (North York, ON, Canada). Water for
solution preparation was purified with a Milli-Q Reagent Water System (Millipore,
Billerica, MA).
Cells
All four cell lines were obtained from ATCC (Manassas, VA) and grown in 75 cm2 cell
culture flasks (Corning Incorporated, Corning, NY). J774A.1 macrophages and NIH/3T3
fibroblasts were cultured in Dulbecco’s modified Eagle’s medium (DMEM, without sodium
pyruvate) that was supplemented with 10% fetal bovine serum, 100 units/ml penicillin, 100
μg/ml streptomycin and 2 mM glutamine (all from Invitrogen, Grand Islands, NY). These
cells were maintained in a humidified atmosphere of 10% CO2 and 90% air at 37 °C.
HepG2/C3A cells were cultured in Minimum Essential Medium (MEM) with 2 mM L-
glutamine and Earle’s salts, supplemented with 0.1 mM non-essential amino acids, 1.0 mM
sodium pyruvate, 10 % fetal bovine serum, 100 units/ml penicillin, and 100 μg/ml
streptomycin. OMK cells were cultured in Minimum Essential Medium, Alpha (AMEM)
(Mediatech, Herndon, VA) that was supplemented as for HepG2/C3A cells. These two cell
lines were maintained in a humidified atmosphere of 5% CO2 and 95% air at 37 °C. Culture
medium was renewed every 2 - 4 days for all cell lines.
To subculture J774A.1 macrophages, cells were dislodged with a scraper, counted with a
hemocytometer (Hausser and Son, Philadelphia, PN), and plated at a concentration of 0.5 ×
106 cells per flask. OMK, HepG2/C3A, and NIH/3T3 cells were removed using 0.25%
trypsin plus 1mM EDTA in PBS (Invitrogen) and subcultured at the same starting density as
J774A.1 cells. NIH/3T3 cells were subcultured before reaching 90% confluency. For
calorespirometry (see below), cells were grown on Cytodex 1 micro-carrier beads (Sigma-
Aldrich, St. Louise, MO) in a stirred culture system. To ensure that the cell cultures were
mycoplasma free, the MycoAlert Mycoplasma Detection Kit (Cambrex Bio Science
Rockland, Inc., Rockland, ME) was used periodically.
Hepatocyte isolation and culture
Hepatocyte culture medium consisted of DMEM supplemented with 10% fetal bovine
serum, 7 ng/ml glucagon (Bedford Laboratories, Bedford, OH), 7.5 mg/ml hydrocortisone
(Pharmacia Corporation, Kalamazoo, MI), 0.5 U/ml insulin (Eli Lilly, Indianapolis, IN), 20
ng/ml epidermal growth factor (Sigma Chemical Co., St. Louis, MO), 200 U/ml penicillin,
and 200 mg/ml streptomycin. Hepatocytes were obtained from adult female Lewis rats
(150–200g; Charles River Laboratories, Boston, MA). A two-step procedure for collagenase
perfusion, modified from Seglen [26], was used for hepatocyte isolation as described
previously [27-29]. Typically, 200 – 300 million hepatocytes were obtained using all lobes
of the liver from one rat, and cell viability was >90% as determined by trypan blue
exclusion. Tissue culture dishes (60 mm diameter) were coated with a solution of type I rat
tail collagen (0.11 mg/ml) for 30 min at 37 °C. After rinsing the dishes twice with phosphate
buffered saline (PBS), 1-3 million hepatocytes were seeded in 2 ml culture medium–
equilibrated with 10% CO2 and 90% air at 37 °C.
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Cell viability and activity assays
Cells were grown in the presence and absence of AICAR and viability assessed by two
methods. Cells were counted at various time points with a hemocytometer after diluting the
sample 1:1 with 0.4% trypan blue solution (Sigma, St. Louise, MO). Alternatively, the
metabolic activity of the cells was monitored with alamarBlue™ (BioSource International,
Inc., Camarillo, CA). A working solution of alamarBlue™ was prepared by diluting the
commercial stock solution 10-fold with culture medium without phenol red. Then 2 ml of
this working solution was added to each well of a 12 well Nunclun™ multidish (Fischer
Scientific, Pittsburg, PA). After adding 20,000 to 40,000 cells to each well, the absorbance
at λ = 570 nm and λ = 600 nm was measured with a micro plate reader (Spectramax Plus,
Molecular Devices, Sunnyvale, CA) at selected time points. The percent of reduced
alamarBlue™ (RA%) was calculated as: RA% = [A570 – A600 · Ro] · 100, where A570 and
A600 are the absorbances at wavelengths of 570 nm and 600 nm after subtracting the
absorbance of culture medium without alamarBlue™. Ro is the ratio of A570 to A600 for
culture medium containing 10% alamarBlue™.
All cell types were plated at a density of 2 × 106 cells and left untreated for 24 h. Media was
exchanged and experimental plates were exposed to 1mM AICAR for 24 h. Cells grown in
culture dishes were washed 4 times with 25 ml of ice-cold PBS, and analysis of the final
wash solution by HPLC confirmed the absence of residual AICAR. Cellular protein was
quantified using a modified Lowry assay according to Peterson [30] with BSA as the
standard.
High performance liquid chromatography (HPLC) of nucleotides and analogues
Cell culture plates were placed on ice, and cells were removed using a cell scraper. Acid
soluble extracts of cell suspensions were prepared as previously described [31] by adding
ice-cold 70% perchloric acid to a final concentration of 7% (w/v). Acid insoluble fractions
were removed by centrifugation for 10 min at 13,000 g and 4 °C (Eppendorf Centrifuge
5417R, Fischer Scientific, Pittsburg, PA). Extracts were neutralized with ice-cold 5 M
K2CO3 and stored at −80 °C until analyzed. Prior to the HPLC analysis, the potassium
perchlorate precipitate was removed by centrifugation as above. Analyses were performed
using a Dionex HPLC system (Dionex, Sunnyvale, CA), which included a PDA-100
photodiode array detector, GP-50 gradient pump, AS50 auto-sampler and AS50 thermal
compartment. Samples were held at 4 °C in the auto-sampler and applied to a 4.6 mm × 25
cm reversed phase column (Synergy 4 μ Hydro RP 80A, Phenomenex, Torrance, CA). The
samples were eluted isocratically for 15 min at a flow rate of 1 ml/min at 30 °C with a
starting buffer of 50 mM K2HPO4/KH2PO4 (pH 5.8) that contained 10 mM
tetrabutylammonium bisulfate. Then a linear gradient of acetonitrile (0% to 25% in starting
buffer) was applied over 40 min. The absorbance of the effluent was monitored with a
photodiode array detector at wavelengths from λ = 190 nm to λ = 390 nm. Peaks were
identified by comparison with retention times of standards, as well as by analyses of peak
spectra from a recorded 3d-field with Chromeleon™ software (Dionex, Sunnyvale, CA).
Concentration of nucleotides was determined from measurement of peak area at λ = 260 nm.
Calibration curves were linear over the range assayed.
Microcalorimetry and respirometry
To assess the metabolic status of NIH/3T3 mouse fibroblasts, we employed simultaneous
microcalorimetry and respirometry [32-34]. The simultaneous measurement of heat flux and
oxygen flux (calorespirometry) not only yields baseline estimates of energy flow but also
can be used to non-invasively evaluate whether or not anaerobic pathways are contributing
to overall cellular metabolism. If isolated cells are incubated under conditions that promote a
fully aerobic metabolism, then the experimentally determined ratio of kilojoules of heat
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dissipated per mole of oxygen consumed (i.e., the calorimetric-respirometric ratio, or CR
ratio) should fall within the range of the theoretical oxycaloric equivalent (−430 to −480 kJ
mol O2−1; [32]). However, if the CR ratio is markedly higher (i.e. more negative) than −430
to −480 kJ mol O2−1, then an anaerobic contribution to energy production is indicated.
The LKB 2277 thermal activity monitor (Bromma, Sweden) was used to measure the heat
dissipation of cells in suspension. A 4 ml sealed ampoule that contained 2.7 ml of water was
used as a reference vessel. Static and dynamic calibrations against water in both ampoules
were performed before the heat signal was measured. For the biological experiments, water
in the sample ampoule was replaced with 2.7 ml of cell suspension. This total suspension
contained between 130,000 and 250,000 cells in culture medium equilibrated with 10% CO2
and 90% air. All calorimetric measurements were performed at 37 °C. A 2 h period for
thermal equilibration was allowed after the ampoule was lowered into the calorimeter, and
then the heat flow (μW) was recorded for 20 h. Under experimental conditions promoting
cell proliferation, the heat flux increased continuously. In these cases, the heat flux was
corrected for the increase in cell number by extrapolation back to the cell count at time zero.
Freezing of cell lines and primary hepatocytes
All cell lines (HepG2/C3A, J774.A1, NIH/3T3, and OMK) were agitated with a vortex
mixer for 30 min at 30 °C with 200 mM 3-O-Methyl-D-gluco-pyranose (3-OMG) dissolved
in cell culture medium in order to preload this cryoprotectant. Control cells received no
AICAR exposure, and experimental cells were pretreated with 1 mM AICAR for 24 h prior
to loading of 3-OMG. Cells were then sedimented by centrifugation (10 min at 10,000 g and
4 °C), and the medium was replaced with Hypo Thermosol FRS (Biolife Solutions, Bothell,
WA) that also contained 200 mM 3-OMG. Cells were chilled in a controlled-rate freezer (1
°C/min, seeding at −6 °C; Cryologic Pty, Mulgrave, Australia) to −80 °C and stored in
liquid nitrogen at −196 °C for 24 h. After this time, the cells were thawed rapidly at 37 °C
and plated in cell culture medium. Cell viability was determined by trypan blue exclusion 24
h after plating and expressed as a percentage of cells that were present before freezing.
Freshly isolated hepatocytes (2 × 106 cells/ml) were incubated for 60 min at 37 °C with 200
mM 3-OMG dissolved in cell culture medium, with or without 0.5 mM AICAR. After the
incubation, cells were sedimented by centrifugation (10 min at 10,000 g and 4 °C), and the
medium was replaced with Hypo Thermosol FRS that also contained 200 mM 3-OMG.
Cells were chilled in the controlled rate freezer (0.5 °C/min, seeding at −10 °C) to −80 °C
and stored in liquid nitrogen at −196 °C for 24 h. After this time, the cells were thawed
rapidly at 37 °C and plated on collagen coated plates in cell culture medium. Cell viability
was determined as above.
Statistical analyses
Statistical significance between groups was evaluated with a one-way ANOVA on ranks
followed by the Student-Newman-Keuls Method (for groups with equal sample sizes) or
Dunn’s test (for groups with unequal sample sizes) for all pair-wise comparison of means, P
> 0.05, with SigmaPlot© for Windows Version 11.0 (SPSS Inc., Chicago, IL). Error
propagation was calculated after the method of Doerfel [35].
RESULTS
Metabolic profiles of NIH/3T3 mouse fibroblasts
In order to measure the impact of acute exposure of AICAR on NIH/3T3 mouse fibroblast,
we characterized cells grown on Cytodex 1 microcarrier beads. Evaluating the metabolic
poise of cells (i.e., the relative contributions of anaerobic and aerobic metabolism) is
important for determining whether culture conditions are optimal for maintaining a fully
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aerobic state under our treatment conditions. First, total heat dissipation rate was measured
for control fibroblasts, and these values varied depending on the cell density on the carrier
beads. At low cell density (about 18 h after seeding), the heat output was −18.4 ± 1.6 μW
per million cells (n = 5, ±SE), and this value increased to −28.2 ± 1.9 μW per million cells
(n = 5, ±SE) after entering the exponential growth phase. In cultures that reached a high
density and therefore exited the exponential growth phase, heat dissipation decreased to
−14.9 ± 0.7 μW per million cells (n = 4, ±SE) (Fig. 1). Second, during exponential growth
of the culture there was an increase in the CR ratio of cells, which suggests that the
contribution of anaerobic pathways to overall metabolic rate was elevated (Fig. 1). As the
culture became contact inhibited (confluence >80%), the CR ratio returned to a value
statistically the same as the theoretical oxycaloric equivalent for mixed substrate respiration
(−450 kJ/mol O2) (n = 3; P > 0.05). Exposure of cells during exponential growth
(confluence ~50%) to 2 mM AICAR for 1 h induced a drop in heat dissipation by about 20%
with respect to the control (Fig. 2). A further reduction can be observed by adding 20 mM of
the glycolytic inhibitor 2-deoxy-D-glucose (2-DG). A combination of AICAR and 2-DG led
to a 50% depression in energy flow (Fig. 2).
Depression of cell proliferation and alamarBlue™ reduction by AICAR
A convenient way to assess metabolic activity and proliferation of cells is by measuring the
reduction of the redox-indicator alamarBlue™. Exposure of NIH/3T3 cells to 2 mM AICAR
for 1 h inhibited the reduction of alamarBlue™ by about 23% after 24 h and by about 15%
after 48 h (Fig. 3A). However, the impact on proliferation was far less pronounced. Cell
counts did not reveal any significant reduction in cell proliferation 24 h after transient
exposure to AICAR, and only a modest reduction of about 10% was observed after 48 h
(Fig. 3B).
One goal of the present study was to induce a stasis-like phenotype by pharmacological
intervention in an attempt to increase cell viability after cryopreservation. Because of the
weak correlation between alamarBlue™ reduction and cellular proliferation observed in
NIH/3T3 cells after short-term AICAR treatment, we decided to monitor proliferation of
NIH/3T3 fibroblasts and several other cell lines after long-term (24 h) exposure to AICAR.
Continuous exposure to 1 mM AICAR for 24 h reduced proliferation of NIH/3T3 cells by
about 40% (Fig. 4). Surprisingly, we found that the effect of AICAR on cell proliferation
varied greatly between cell lines. After 24 h exposure to AICAR, proliferation of owl-
monkey kidney cells (OMK) was 90% ± 6% of untreated control cells, and proliferation
J774 mouse macrophage cells was 33% ± 4% of controls (± SE, n = 5 - 7) (Fig.4). To
investigate whether or not these AICAR-induced differences in proliferation were the result
of differential capacities among cell types for AICAR interconversion and/or other impacts
on cellular nucleotide pools, we analyzed cell extracts with HPLC.
Impact of AICAR on adenylates and adenylate analogues in cell lines and primary
hepatocytes
Figure 5 shows a representative HPLC chromatogram of an extract from NIH/3T3 cells that
were exposed to 1 mM AICAR for 24 h. All compounds of interest exhibited baseline
separation by this technique and a signal-to-noise ratio greater than 20:1. Our analyses not
only revealed high intracellular concentrations of AICAR and ZMP but also large
accumulations of the multi-phosphorylated compounds ZDP and ZTP.
All cell lines investigated showed some capacity to synthesize ZMP from AICAR, but the
amount of ZMP accumulated after 24 h of 1 mM AICAR exposure varied significantly
among cell types (Table 1). In contrast to all other cell types, the OMK cells did not
accumulate detectable levels of ZDP or ZTP. For all cells except NIH/3T3 fibroblasts,
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AICAR exposure had a significant impact on the steady-state concentrations of ATP, ADP
and AMP. The most dramatic effect was seen with primary hepatocytes, which showed an
80% drop in ATP levels after exposure to 1 mM AICAR. These cells were very sensitive to
the drug. Hepatocyte morphology was substantially affected after 24 h of incubation (data
not shown), and viability was eventually compromised (a noticeable number of dead cells
were washed from the plates prior to HPLC analyses). A striking difference was observed
between primary hepatocytes and the hepatocellular carcinoma cell line HepG2/C3A. After
exposure of HepG2/C3A cells to 1 mM AICAR, ATP levels actually increased from 24.09 ±
2.02 to 35.90 ± 3.66 nmol per mg protein (n = 4-5, ± SD) (Table 1).
Impact of AICAR incubation on viability post-freezing
To test whether or not metabolic preconditioning with AICAR improves survival after
cryopreservation, we exposed the four cell lines (J774.A1, HepG2/C3A, NIH/3T3, and
OMK) for 24 h to 1 mM AICAR, a dose previously determined to be tolerated by these
cells. This treatment impacted the ‘effective adenylate ratio’ (Table 1) and significantly
inhibited proliferation rates of J774.A1, HepG2/C3A and NIH/3T3 cells (Fig. 4). For these
metabolic preconditioning studies with AICAR, we also added a cryoprotectant (3-OMG)
that has been shown to improve viability in mammalian cells after cryopreservation. It has
been shown that the non-metabolizable sugar 3-OMG is readily loaded into cells via the
glucose transporter and acts as a non-toxic cryoprotectant [36,45]. Thus, any increase or
decrease in cell viability due to AICAR exposure could be readily detected against the
background of freeze tolerance promoted by 3-OMG. We found that the cryoprotective
effect of 3-OMG (200 mM) differed among cell lines (3% - 20% viability after freezing, Fig.
6), and that cell lines with a large reduction in proliferation after exposure to AICAR (Fig.
4) also showed highly significant improvements in viability after cryopreservation (Fig. 6).
For example, the viability of J774.A1 cells increased over 4-fold from 7.8% ± 0.6% with 3-
OMG alone to 33% ± 1.5% (n = 9, ± SE) after pre-treatment with AICAR.
To evaluate whether or not metabolic preconditioning with AICAR also can improve
survival during cryopreservation of primary hepatocytes, we limited the exposure of these
cells to the highest dose that was well tolerated. Our results with a wide range of
concentrations (0.1-2.5 mM for 1 h) revealed that AICAR concentrations higher than 0.5
mM led to a change in cell morphology and a decrease in viability of primary cells, as
assessed 24 h post exposure (data not shown). In support of these findings, Guigas et al. [37]
showed that 0.5 mM AICAR promoted maximal activation of AMPK in primary rat
hepatocytes after 30 min. Control cells exposed to 200 mM 3-OMG for 1 h and frozen in
Hypo Thermosol FRS (supplemented with 200 mM 3-OMG) exhibited a viability of 39.5%
± 4.0% (± SE, n = 3) after thawing. Exposure of experimental cells to 200 mM 3-OMG plus
0.5 mM AICAR for 1 h significantly increased the viability (P < 0.05) over 3-OMG alone
(Fig. 7).
DISCUSSION
The ability to increase the effective steady-state ratio of AMP to ATP in cells provides an
opportunity to evaluate the impact of this change on rates of metabolism and cellular
proliferation. In natural states of cellular stasis like diapause (a dormant state entered under
normoxia, euthermia and full hydration) and anoxia-induced quiescence, a repeated theme is
that the AMP:ATP ratio is elevated and tightly correlated with the arrest of metabolism
[2,38,42-44]. A high AMP:ATP ratio activates AMPK, which serves to conserve cellular
energy stores [10]. Thus, we predicted that the AMPK cascade could be exploited for
preconditioning mammalian cells. As shown in this study, the induction of a stasis-like
phenotype improved cell viability during cryopreservation.
Menze et al. Page 7













In addition to quantifying the improved viability with AICAR treatment, we employed
several methods to monitor AICAR-mediated depression of cell metabolism. Calorimetry
revealed that the overall energy flow of NIH/3T3 cells depends on the cell density. As
expected the highest heat output was found for cells that were measured during their
exponential growth phase, and all following studies were conducted on cells in this phase. A
transient exposure to 2 mM AICAR leads to a 20% reduction in energy flow of NIH/3T3
cells measured as an acute decrease in heat dissipation. This value correlates well with the
23% depression in alamarBlue™ reduction. A further reduction in heat dissipation to about
50% of control was observed after addition of 20 mM 2-deoxy-D-glucose (2-DG). 2-DG
crosses the cell membrane via the glucose transporter and is phosphorylated by hexokinase
(EC 2.7.1.1) to 2-deoxy-D-glucose-6-phosphate (2-DGP), which accumulates inside the cell
[39]. 2-DGP inhibits glucose-6-phosphate isomerase (EC 5.3.1.9) activity [40] and thereby
reduces carbon flux through the glycolytic pathway.
In terms of the impact of AICAR on cell proliferation, the depressed proliferation we
observed did not correlate with the accumulation of ZMP alone (r2 = 0.04, data not shown),
but rather was related to the fold-change in the effective adenylate ratio ([AMP]+[ZMP])/
[ATP]; r2 = 0.77). This finding underscores the need to quantitatively evaluate the impact of
AICAR on the total adenylate pool before any effects of AICAR exposure are ascribed to
specific activation of AMPK. The general view that AMPK is modulated by the AMP:ATP
ratio rather than just by the concentration of a single nucleotide [14] is supported by our
results in Figure 8A. The amount of ZMP produced by a given cell line in response to a 1
mM AICAR exposure varied widely from 19.9 to 68.6 nmol/mg protein. Thus, the
accumulation of ZMP cannot be predicted a priori, and a detailed analysis of the specific
ability of a given cell line to synthesize ZMP should be performed before any effects of the
drug are attributed to ZMP accumulation.
Cellular effects of AICAR are not necessarily caused by AMPK activation and include
inhibition of Complex I of the respiratory chain by ZMP directly [37] and competition with
adenosine for the nucleoside transporters in the plasma membrane [17]. In addition, high
levels of di- and tri-phosphorylated forms of ZMP (e.g., ZDP and ZTP) may accumulate and
interact with multiple cellular processes. To substantiate the phosphorylation of AICAR to
ZMP, it is important to evaluate cell extracts under the conditions used for a given
experiment. Not every cell line expresses sufficiently-high adenosine kinase activity to
produce the necessary concentrations of ZMP [23-25]. Furthermore, ZMP can enter the
pathway of purine synthesis and may affect the concentration of several purines and purine
precursors [19]. Indeed, given a sufficient exposure time to AICAR, we showed that all cell
types except OMK cells accumulate substantial amounts of ZDP and ZTP (Table 1), which
may have unknown physiological consequences. Thus we speculate that OMK cells would
be ideal for investigating ZMP-specific effects, due to their lack of ZDP or ZTP. AICAR
concentrations of above 1 mM could be used to increase ZMP levels even further in such
studies.
We found that metabolic preconditioning with AICAR increased the viability after
cryopreservation of several cell lines (Fig. 6). Similar to the depression in proliferation, the
fold-increase in viability was highly correlated to the fold-increase in the ‘effective
adenylate ratio’ (r2 = 0.97). We next investigated whether or not the effect of AICAR was
limited to immortalized cell lines that rapidly proliferate, or if AICAR also could be used to
precondition primary cells. Primary rat hepatocytes were more sensitive to AICAR exposure
and responded with drops in both cellular ATP levels (Tab.1) and viability (data not shown)
when exposed to 1 mM of the drug for 24 h. By optimizing exposure time and concentration
of AICAR, a quiescent phenotype could also be induced in primary hepatocytes without the
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undesirable side effects. Exposure to 0.5 mM AICAR and 200 mM 3-OMG for 1 h increased
viability by 14% compared to controls without AICAR.
This study is the first to report that metabolic preconditioning with AICAR increases freeze
tolerance of several cell lines and primary rat hepatocytes. Another metabolic adjustment
exhibited by animal species that are naturally tolerant to environmental stress (dehydration
freezing, anoxia, etc.) is the depression of oxidative phosphorylation [1-7]. Likewise,
Bonnet et al. [41] presented evidence that mammalian cells with a high propensity for
survival (e.g., cancer cells) direct pyruvate flux away from the TCA cycle and toward lactate
production by inactivation of the pyruvate dehydrogenase complex. Thus it seems that cell
stability/survival can be enhanced and apoptosis depressed by turning down oxidative
phosphorylation fueled by pyruvate. Experiments to exploit this mechanism as a means to
metabolically precondition cells for improved survivorship during desiccation and freezing
are currently underway. Integrating such concepts of cell stasis into protocols for
biostabilization may bring us closer to the exciting possibility of engineering mammalian
cells and tissues that are more tolerant to long-term storage.
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Heat dissipation for mouse NIH/3T3 fibroblasts attached to micro-carrier beads as a function
of cellular confluency. The calorimetric-respirometric ratios (CR ratios) are provided above
each histogram bar (n = 3, ± SE; *P < 0.05).
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Influence of metabolic modulators on heat dissipation of mouse NIH/3T3 fibroblasts. Cells
were exposed for 1 h to 2 mM AICAR, 20 mM 2-deoxy-D-glucose (2-DG) or a combination
of both (n = 3 - 5, ± SE; *P < 0.05).
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Influence of 60 min exposure to 2 mM AICAR on the (A) metabolic activity of mouse NIH/
3T3 fibroblasts measured by alamarBlue™ reduction and (B) proliferation measured one
day (d1) and two days (d2) after this transient exposure (n = 5 - 7, ± SE; *P < 0.05).
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Impact of 24 h exposure to 1 mM AICAR on proliferation in several cell lines. (n = 5-7, ±
SE). OMK, owl-monkey kidney cells; C3A, HepG2/C3A hepatocellular carcinoma cells
(human); 3T3, NIH/3T3 mouse fibroblasts; J774, J774 mouse macrophages.
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Analysis of adenine nucleotide levels in mouse fibroblast cells (NIH/3T3). A representative
HPLC chromatogram of a cell extract after 24 h incubation with 1 mM AICAR is shown.
All compounds of interest show baseline separation and accumulations of di- and tri-
phosphorylated forms of ZMP (e.g. ZDP and ZTP) are observed.
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Pre-exposure to AICAR (1 mM, 24 h) increases viability after freezing in some mammalian
cell lines when frozen in presence of 3-OMG. AICAR treatment is indicated by a (+) sign
after the cell line designation. Viability was assessed by trypan blue exclusion (membrane
integrity) 24 h after plating of thawed samples and is expressed as the percentage of cells
prior to freezing (n = 6-9, ± SE; *P < 0.01).
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Influence of 60 min exposure to AICAR (0.5 mM) on viability of primary hepatocytes post-
freezing. Viability was assessed as trypan blue exclusion (membrane integrity) 24 h after
plating of cells and is expressed as a percentage of the cells originally plated (n = 3, ± SE;
*P < 0.05).
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(A) Depression in cell proliferation is correlated with the fold-increase in the effective
adenylate ratio after AICAR treatment ([AMP]+[ZMP])/[ATP]), expressed relative to the
control value ([AMP]/[ATP]). (B) Fold-increase in cell viability after freezing (number of
viable cells after freezing without AICAR/number of viable cells after freezing with
AICAR). The effect of AICAR on viability after freezing positively correlates (r2 = 0.94)
with the fold-increase in the ‘effective adenylate ratio’.
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